← 홈

ADC

1,032개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-6 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,032개
ADCBiologicstaleSun Yat-sen UniversityPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, RC48+Furmonertinib, 2L+)

Non Small Cell Lung Cancer; ERBB2 Mutation-Related Tumors · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleChanghai HospitalPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, RC48+PD-1+platinum-based)

Esophageal Squamous Carcinoma; HER-2 Protein Overexpression · PD-1

#PD-1#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 ACTIVE
ADCBiologicstaleRegeneron PharmaceuticalsPhase 1

REGN5093-M114 (REGN5093-M114)

Advanced NSCLC · Advanced NSCLC

#AdvancedNSCLC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 DISCONTINUED
ADCBiologicstaleOu Bai, MDPhase 2

RMTO (RMTO)

DLBCL - Diffuse Large B Cell Lymphoma · DLBCL - Diffuse Large B Cell Lymphoma

#DLBCL-DiffuseLargeBCellLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleXijing HospitalPhase 2

RC48-ADC (Recombinant humanized anti-HER2 monoclonal antibody-MMAE coupling agent, Recombinant humanized anti-HER2 monoclonal antibody-MMAE coupling agent (RC48-ADC))

Breast Cancer; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 ACTIVE
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Rilvegostomig + TDXd (Rilvegostomig + TDXd)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleServier Bio-Innovation LLCPhase 2

S227928 (S227928)

Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML); Myelodysplastic Syndrome (MDS)/AML · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 1상태 DISCONTINUED
ADCBiologicstaleSeagen Inc.Phase 1

SGN-CD123A (SGN-CD123A)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 DISCONTINUED
ADCBiologicstaleSeagen Inc.Phase 1

SGN-CD19B (SGN-CD19B)

Non-Hodgkin Lymphoma; DLBCL · CD19

#CD19#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 DISCONTINUED
ADCBiologicstaleSeagen Inc.Phase 1

SGN-CD48A (SGN-CD48A)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 DISCONTINUED
ADCBiologicstaleSeagen Inc.Phase 1

SGN-CD70A (SGN-CD70A)

Renal Cell Carcinoma; Mantle-Cell Lymphoma · Renal Cell Carcinoma

#RenalCellCarcinoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleFudan UniversityPhase 2

SHR-4602 (SHR-4602)

Breast Neoplasm; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleJiangsu HengRui Medicine Co., L…Phase 1

SHR-A1403 (SHR-A1403)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 ACTIVE
ADCBiologicstaleUnion Hospital, Tongji Medical …Phase 2

SHR-A1811,tratuzumab,pyrotinib,Nab-Paclitaxel (SHR-A1811,tratuzumab,pyrotinib,Nab-Paclitaxel)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleChina Medical University, ChinaPhase 2

SHR-A1904 (SHR-A1904)

Gastric Cancer; HER2 + Gastric Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleSichuan Kelun-Biotech Biopharma…Phase 2

SKB105 for injection Monotherapy (SKB105 for injection Monotherapy)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleSOTIO Biotech a.s.Phase 2

SOT102 (SOT102)

Pancreatic Cancer · Pancreatic Cancer

#PancreaticCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 DISCONTINUED
ADCBiologicstaleThe First Affiliated Hospital w…Phase 2

normal (SOX, SOX(normal))

GC/GEJC · GC/GEJC

#GCGEJC#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleSorrento Therapeutics, Inc.Phase 1

STI-3258 (STI-3258)

Relapsed Solid Neoplasm; Refractory Cancer · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 DISCONTINUED
ADCBiologicstaleSutro Biopharma, Inc.Phase 1

STRO-001 (STRO-001)

B-cell Lymphoma; Non Hodgkin Lymphoma · B-cell Lymphoma

#B-cellLymphoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE

48 / 52 페이지

← 이전다음 →